Welcome to our dedicated page for Genworth Finl SEC filings (Ticker: GNW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Genworth Financial, Inc. (NYSE: GNW) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including current reports, annual reports, and quarterly reports filed with the U.S. Securities and Exchange Commission. As a publicly traded holding company with operations in long-term care insurance, life and annuities, and U.S. mortgage insurance through Enact Holdings, Inc. (Nasdaq: ACT), Genworth uses these filings to present detailed financial and segment information.
Investors reviewing GNW SEC filings can examine how Genworth reports results for its Enact, Long-Term Care Insurance, and Life and Annuities segments, along with holding company activities. Filings such as Form 10-K and Form 10-Q typically include discussions of net income, adjusted operating income, segment performance, investment results, statutory capital measures, and risk-based capital ratios for U.S. life insurance subsidiaries. They also describe Genworth’s use of non-GAAP measures, including how adjusted operating income is defined and reconciled to GAAP net income.
Current reports on Form 8-K, such as the filing dated November 5, 2025, document material events including the release of quarterly financial results and the availability of related press releases and financial supplements. These filings often reference exhibits that contain detailed data tables and segment disclosures.
Through Stock Titan, users can follow GNW filings in real time as they are posted to the SEC’s EDGAR system. AI-powered tools summarize lengthy documents, highlight key themes such as capital allocation, share repurchase authorizations, segment trends, and legal or regulatory updates, and help clarify the implications of complex items like liability remeasurement in long-term care, reserve releases in mortgage insurance, or changes in market risk benefits. The filings page can also surface insider transaction reports on Form 4 and proxy-related disclosures when available, giving a fuller view of executive and governance-related information.
Genworth Financial EVP and General Counsel Gregory S. Karawan reported equity compensation activity tied to vested Restricted Stock Units on February 26, 2026. Restricted Stock Units convert into Common Stock on a 1:1 basis.
He acquired 27,144 shares of Common Stock and separately 25,316 shares of Common Stock through exercises or conversions of Restricted Stock Units. To cover tax withholding on these vestings, the company withheld 7,533 shares of Common Stock at $8.62 per share and an additional 7,026 shares at $8.62 per share, classified as dispositions for tax-withholding purposes rather than open-market sales.
After these transactions, he directly owned 355,717 shares of Genworth Financial Common Stock and indirectly held 4,736.201 shares through a 401(k) account.
Genworth Financial EVP and Chief Risk Officer Mark Blakeley Hodges reported multiple equity award transactions. On February 26, 2026, Restricted Stock Units vested and converted into Common Stock on a 1:1 basis, resulting in the acquisition of 21,716 and 18,753 shares of Common Stock at $0.00 per share through derivative exercises.
To cover tax withholding on these vested awards, the company withheld 6,537 and 5,645 shares of Common Stock at $8.62 per share as tax-withholding dispositions. After these transactions, Hodges directly owned 139,111 shares of Genworth Financial Common Stock, with an additional 4,530.741 shares held indirectly through a 401(k) plan.
Genworth Financial EVP and Chief HR Officer Melissa Hagerman reported equity award activity related to restricted stock units (RSUs). On February 26, 2026, RSUs vested and converted into Common Stock on a 1:1 basis, increasing her direct holdings.
To cover tax withholding on the vested RSUs, the company withheld shares of Common Stock at a price of $8.62 per share, recorded as tax-withholding dispositions rather than open-market sales. After these exercises, conversions, and withholdings, Hagerman continued to hold Common Stock directly.
Genworth Financial executive Jamala M. Arland, Pres. & CEO, U.S. Life Insurance, reported multiple equity award transactions. On February 26, 2026, 27,144 and 30,004 Restricted Stock Units vested and converted into an equal number of Genworth common shares on a 1:1 basis.
The Form 4 also shows dispositions of 8,171 and 9,032 common shares at $8.62 per share. Footnotes explain these were shares withheld by the company to satisfy tax withholding obligations upon RSU vesting, rather than open-market sales.
Genworth Financial outlines a diversified insurance platform built around three areas: Enact mortgage insurance, a Closed Block of legacy life, annuity and long-term care, and newer CareScout aging‑care businesses.
Enact, which remains majority‑owned and consolidated, focuses on U.S. private mortgage insurance and returned $407 million of capital to Genworth Holdings in 2025. Genworth is using these funds, alongside cash flow, to back growth and capital management, including a share repurchase program under which it has bought back $828 million of common stock since 2022, within a current authorization of up to $350 million.
CareScout is central to Genworth’s growth plans. CareScout Services is building a nationwide network of roughly 790 home‑care providers and added senior living reach through the October 2025 acquisition of Seniorly. CareScout Insurance launched a new individual long‑term care product, Care Assurance, available in 40 states by February 2026, with conservative pricing and access to CareScout’s quality network.
The Closed Block legacy subsidiaries no longer write new life, annuity or GLIC long‑term care policies, but continue servicing in‑force business and pursuing multi‑year in‑force rate actions. From 2012 to 2025, approved long‑term care rate increases and benefit reductions produced an estimated cumulative economic benefit of $34.5 billion on a net present value basis, supporting the aim of keeping these entities self‑sustaining.
Genworth emphasizes enterprise risk management, reinsurance and regulatory capital. Enact remains in compliance with PMIERs and state risk‑to‑capital limits, and its main subsidiary EMICO holds strong financial strength ratings, including an S&P rating of A- and Moody’s A2. Legacy life subsidiaries carry weaker A.M. Best ratings, but their risk‑based capital ratios exceed regulatory action thresholds. As of June 30, 2025, non‑affiliate holders owned common equity with an aggregate market value of about $3.1 billion, and as of February 24, 2026, there were 387,611,047 common shares outstanding.
Genworth Financial executive Taylor Morris, EVP & CIO, reported beneficial ownership of 64,563 Restricted Stock Units (RSUs) on an initial Form 3. These RSUs vest and convert into common stock in equal parts on May 21, 2026, May 21, 2027, and May 21, 2028, settling into common shares on a 1:1 basis.
Genworth Financial reported modest fourth-quarter 2025 results, with net income available to common stockholders of $2 million and adjusted operating income of $8 million, or $0.02 per diluted share. For full-year 2025, net income was $223 million and adjusted operating income was $144 million, or $0.35 per diluted share.
Results were driven by the Enact mortgage insurance segment, which delivered adjusted operating income of $146 million in the quarter, supported by low loss ratios and strong capital with an estimated PMIERs sufficiency ratio of 162%. The Closed Block segment posted a fourth-quarter adjusted operating loss of $114 million, including a $159 million loss in long-term care from higher claims and unfavorable assumption updates. Legacy insurance companies reported 2025 statutory pre-tax income of $71 million and an estimated RBC ratio of 300%, while holding-company cash and liquid assets ended the year at $234 million. Genworth also returned capital to shareholders, executing $94 million of share repurchases in the quarter and $245 million in 2025, totaling $790 million since program inception.
Genworth Financial executive Andrea Lynn White, President & CEO of CareScout Insurance, reported equity-based compensation activity involving company stock. On February 13, 2026, 21,892 Restricted Stock Units vested and were converted into the same number of Genworth common shares at no cash exercise price.
To cover related tax withholding obligations on this vesting, 6,076 common shares were withheld and disposed of at $8.92 per share, as indicated by the tax-withholding disposition code. After these transactions, White directly owned 684,071 shares of Genworth common stock.
Genworth Financial EVP & Chief Financial Officer Jerome T. Upton reported equity award activity involving restricted stock units and common shares. On February 13, 2026, 36,486 Restricted Stock Units vested and were converted into 36,486 shares of Common Stock on a 1:1 basis at no exercise price. To cover tax withholding on this vesting, 9,701 shares of Common Stock were disposed of at $8.92 per share through share withholding rather than an open-market sale. After these transactions, Upton directly owned 454,773 shares of Genworth Financial common stock.
Genworth Financial EVP & Chief Investment Officer Kelly A. Saltzgaber reported equity award activity. On February 13, 2026, 21,892 Restricted Stock Units were exercised and converted into 21,892 shares of Common Stock at $0.00 per share. To cover tax withholding on the vested units, 6,195 Common shares were withheld at $8.92 per share, leaving Saltzgaber with direct ownership of 68,272 Common shares.